19 May 2022 07:00
RNS Number : 0762M
Inspiration Healthcare Group PLC
19 May 2022
Inspiration Healthcare Group plc
("Inspiration Healthcare" or the "Group")
Mello Investor Conference
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, will be attending the Mello2022 investor conference taking place on Wednesday 25 and Thursday 26 May 2022 at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY.
The Company's Chief Executive Officer, Neil Campbell and Chief Financial Officer, Jon Ballard will be giving presentations to investors on both days. The Company will also be attending the exhibition giving investors an opportunity for informal discussions with management on the Company stand.
For further information on the Mello2022 conference, please visit the event website at https://melloevents.com/mello2022/ .
Enquiries:
Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer | Tel: 0330 175 0000 |
Cadogan PR Alex Walters alex.walters@cadoganpr.com | Tel: 07771 713608 |
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRASFMSIUEESEDI